nodes	percent_of_prediction	percent_of_DWPC	metapath
Valsartan—Blood urea increased—Zoledronate—Paget's disease of bone	0.00688	0.00688	CcSEcCtD
Valsartan—Cramp muscle—Alendronate—Paget's disease of bone	0.00683	0.00683	CcSEcCtD
Valsartan—Swelling—Pamidronate—Paget's disease of bone	0.00656	0.00656	CcSEcCtD
Valsartan—Asthenia—Tiludronate—Paget's disease of bone	0.00656	0.00656	CcSEcCtD
Valsartan—Renal failure acute—Pamidronate—Paget's disease of bone	0.00627	0.00627	CcSEcCtD
Valsartan—Diarrhoea—Tiludronate—Paget's disease of bone	0.00625	0.00625	CcSEcCtD
Valsartan—Atrial fibrillation—Pamidronate—Paget's disease of bone	0.00611	0.00611	CcSEcCtD
Valsartan—Dizziness—Tiludronate—Paget's disease of bone	0.00604	0.00604	CcSEcCtD
Valsartan—Swelling—Zoledronate—Paget's disease of bone	0.00599	0.00599	CcSEcCtD
Valsartan—Photosensitivity reaction—Alendronate—Paget's disease of bone	0.00599	0.00599	CcSEcCtD
Valsartan—Cardiac failure—Pamidronate—Paget's disease of bone	0.00593	0.00593	CcSEcCtD
Valsartan—Renal failure acute—Zoledronate—Paget's disease of bone	0.00573	0.00573	CcSEcCtD
Valsartan—Headache—Tiludronate—Paget's disease of bone	0.00573	0.00573	CcSEcCtD
Valsartan—Atrial fibrillation—Zoledronate—Paget's disease of bone	0.00558	0.00558	CcSEcCtD
Valsartan—Abdominal pain upper—Risedronate—Paget's disease of bone	0.00556	0.00556	CcSEcCtD
Valsartan—Renal impairment—Zoledronate—Paget's disease of bone	0.00556	0.00556	CcSEcCtD
Valsartan—Alopecia—Etidronic acid—Paget's disease of bone	0.00544	0.00544	CcSEcCtD
Valsartan—Nausea—Tiludronate—Paget's disease of bone	0.00543	0.00543	CcSEcCtD
Valsartan—Blood creatinine increased—Pamidronate—Paget's disease of bone	0.00542	0.00542	CcSEcCtD
Valsartan—Muscular weakness—Risedronate—Paget's disease of bone	0.00537	0.00537	CcSEcCtD
Valsartan—Flatulence—Etidronic acid—Paget's disease of bone	0.00528	0.00528	CcSEcCtD
Valsartan—Haemoglobin—Alendronate—Paget's disease of bone	0.00528	0.00528	CcSEcCtD
Valsartan—Haemorrhage—Alendronate—Paget's disease of bone	0.00525	0.00525	CcSEcCtD
Valsartan—Cramp muscle—Pamidronate—Paget's disease of bone	0.00521	0.00521	CcSEcCtD
Valsartan—Muscle spasms—Etidronic acid—Paget's disease of bone	0.00516	0.00516	CcSEcCtD
Valsartan—Bronchitis—Risedronate—Paget's disease of bone	0.00506	0.00506	CcSEcCtD
Valsartan—Blood creatinine increased—Zoledronate—Paget's disease of bone	0.00495	0.00495	CcSEcCtD
Valsartan—Angioedema—Etidronic acid—Paget's disease of bone	0.0049	0.0049	CcSEcCtD
Valsartan—Upper respiratory tract infection—Risedronate—Paget's disease of bone	0.00489	0.00489	CcSEcCtD
Valsartan—Abdominal pain upper—Zoledronate—Paget's disease of bone	0.00483	0.00483	CcSEcCtD
Valsartan—Cramp muscle—Zoledronate—Paget's disease of bone	0.00476	0.00476	CcSEcCtD
Valsartan—Infestation NOS—Risedronate—Paget's disease of bone	0.00469	0.00469	CcSEcCtD
Valsartan—Infestation—Risedronate—Paget's disease of bone	0.00469	0.00469	CcSEcCtD
Valsartan—Neutropenia—Pamidronate—Paget's disease of bone	0.00468	0.00468	CcSEcCtD
Valsartan—Muscular weakness—Zoledronate—Paget's disease of bone	0.00466	0.00466	CcSEcCtD
Valsartan—Upper respiratory tract infection—Pamidronate—Paget's disease of bone	0.00465	0.00465	CcSEcCtD
Valsartan—Alopecia—Alendronate—Paget's disease of bone	0.00464	0.00464	CcSEcCtD
Valsartan—Arthralgia—Etidronic acid—Paget's disease of bone	0.00457	0.00457	CcSEcCtD
Valsartan—Flatulence—Alendronate—Paget's disease of bone	0.0045	0.0045	CcSEcCtD
Valsartan—Dysgeusia—Alendronate—Paget's disease of bone	0.00448	0.00448	CcSEcCtD
Valsartan—Infestation NOS—Pamidronate—Paget's disease of bone	0.00446	0.00446	CcSEcCtD
Valsartan—Infestation—Pamidronate—Paget's disease of bone	0.00446	0.00446	CcSEcCtD
Valsartan—Sinusitis—Risedronate—Paget's disease of bone	0.0044	0.0044	CcSEcCtD
Valsartan—Muscle spasms—Alendronate—Paget's disease of bone	0.00439	0.00439	CcSEcCtD
Valsartan—Renal failure—Pamidronate—Paget's disease of bone	0.00438	0.00438	CcSEcCtD
Valsartan—Infection—Etidronic acid—Paget's disease of bone	0.00435	0.00435	CcSEcCtD
Valsartan—Neutropenia—Zoledronate—Paget's disease of bone	0.00427	0.00427	CcSEcCtD
Valsartan—Upper respiratory tract infection—Zoledronate—Paget's disease of bone	0.00425	0.00425	CcSEcCtD
Valsartan—Haemoglobin—Risedronate—Paget's disease of bone	0.00423	0.00423	CcSEcCtD
Valsartan—Rhinitis—Risedronate—Paget's disease of bone	0.00422	0.00422	CcSEcCtD
Valsartan—Haemorrhage—Risedronate—Paget's disease of bone	0.00421	0.00421	CcSEcCtD
Valsartan—Sinusitis—Pamidronate—Paget's disease of bone	0.00418	0.00418	CcSEcCtD
Valsartan—Pharyngitis—Risedronate—Paget's disease of bone	0.00418	0.00418	CcSEcCtD
Valsartan—Angioedema—Alendronate—Paget's disease of bone	0.00418	0.00418	CcSEcCtD
Valsartan—Urinary tract disorder—Risedronate—Paget's disease of bone	0.00416	0.00416	CcSEcCtD
Valsartan—Connective tissue disorder—Risedronate—Paget's disease of bone	0.00414	0.00414	CcSEcCtD
Valsartan—Urethral disorder—Risedronate—Paget's disease of bone	0.00413	0.00413	CcSEcCtD
Valsartan—Vertigo—Alendronate—Paget's disease of bone	0.00411	0.00411	CcSEcCtD
Valsartan—Infestation NOS—Zoledronate—Paget's disease of bone	0.00407	0.00407	CcSEcCtD
Valsartan—Infestation—Zoledronate—Paget's disease of bone	0.00407	0.00407	CcSEcCtD
Valsartan—Haemoglobin—Pamidronate—Paget's disease of bone	0.00402	0.00402	CcSEcCtD
Valsartan—Rhinitis—Pamidronate—Paget's disease of bone	0.00401	0.00401	CcSEcCtD
Valsartan—Renal failure—Zoledronate—Paget's disease of bone	0.004	0.004	CcSEcCtD
Valsartan—Haemorrhage—Pamidronate—Paget's disease of bone	0.004	0.004	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Etidronic acid—Paget's disease of bone	0.00399	0.00399	CcSEcCtD
Valsartan—Urinary tract disorder—Pamidronate—Paget's disease of bone	0.00395	0.00395	CcSEcCtD
Valsartan—Connective tissue disorder—Pamidronate—Paget's disease of bone	0.00393	0.00393	CcSEcCtD
Valsartan—Paraesthesia—Etidronic acid—Paget's disease of bone	0.00393	0.00393	CcSEcCtD
Valsartan—Urethral disorder—Pamidronate—Paget's disease of bone	0.00393	0.00393	CcSEcCtD
Valsartan—Cardiac disorder—Risedronate—Paget's disease of bone	0.00391	0.00391	CcSEcCtD
Valsartan—Chest pain—Alendronate—Paget's disease of bone	0.00389	0.00389	CcSEcCtD
Valsartan—Myalgia—Alendronate—Paget's disease of bone	0.00389	0.00389	CcSEcCtD
Valsartan—Dyspepsia—Etidronic acid—Paget's disease of bone	0.00385	0.00385	CcSEcCtD
Valsartan—Angiopathy—Risedronate—Paget's disease of bone	0.00382	0.00382	CcSEcCtD
Valsartan—Immune system disorder—Risedronate—Paget's disease of bone	0.0038	0.0038	CcSEcCtD
Valsartan—Mediastinal disorder—Risedronate—Paget's disease of bone	0.0038	0.0038	CcSEcCtD
Valsartan—Constipation—Etidronic acid—Paget's disease of bone	0.00374	0.00374	CcSEcCtD
Valsartan—Cardiac disorder—Pamidronate—Paget's disease of bone	0.00372	0.00372	CcSEcCtD
Valsartan—Infection—Alendronate—Paget's disease of bone	0.00371	0.00371	CcSEcCtD
Valsartan—Mental disorder—Risedronate—Paget's disease of bone	0.00369	0.00369	CcSEcCtD
Valsartan—Malnutrition—Risedronate—Paget's disease of bone	0.00367	0.00367	CcSEcCtD
Valsartan—Angiopathy—Pamidronate—Paget's disease of bone	0.00363	0.00363	CcSEcCtD
Valsartan—Immune system disorder—Pamidronate—Paget's disease of bone	0.00362	0.00362	CcSEcCtD
Valsartan—Flatulence—Risedronate—Paget's disease of bone	0.00361	0.00361	CcSEcCtD
Valsartan—Urinary tract disorder—Zoledronate—Paget's disease of bone	0.00361	0.00361	CcSEcCtD
Valsartan—Mediastinal disorder—Pamidronate—Paget's disease of bone	0.00361	0.00361	CcSEcCtD
Valsartan—Connective tissue disorder—Zoledronate—Paget's disease of bone	0.00359	0.00359	CcSEcCtD
Valsartan—Urethral disorder—Zoledronate—Paget's disease of bone	0.00359	0.00359	CcSEcCtD
Valsartan—Gastrointestinal pain—Etidronic acid—Paget's disease of bone	0.00358	0.00358	CcSEcCtD
Valsartan—Back pain—Risedronate—Paget's disease of bone	0.00355	0.00355	CcSEcCtD
Valsartan—Alopecia—Pamidronate—Paget's disease of bone	0.00354	0.00354	CcSEcCtD
Valsartan—Muscle spasms—Risedronate—Paget's disease of bone	0.00353	0.00353	CcSEcCtD
Valsartan—Malnutrition—Pamidronate—Paget's disease of bone	0.00349	0.00349	CcSEcCtD
Valsartan—Urticaria—Etidronic acid—Paget's disease of bone	0.00348	0.00348	CcSEcCtD
Valsartan—Abdominal pain—Etidronic acid—Paget's disease of bone	0.00346	0.00346	CcSEcCtD
Valsartan—Dysgeusia—Pamidronate—Paget's disease of bone	0.00341	0.00341	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Alendronate—Paget's disease of bone	0.0034	0.0034	CcSEcCtD
Valsartan—Cardiac disorder—Zoledronate—Paget's disease of bone	0.00339	0.00339	CcSEcCtD
Valsartan—Back pain—Pamidronate—Paget's disease of bone	0.00337	0.00337	CcSEcCtD
Valsartan—Muscle spasms—Pamidronate—Paget's disease of bone	0.00335	0.00335	CcSEcCtD
Valsartan—Angioedema—Risedronate—Paget's disease of bone	0.00335	0.00335	CcSEcCtD
Valsartan—Angiopathy—Zoledronate—Paget's disease of bone	0.00332	0.00332	CcSEcCtD
Valsartan—Immune system disorder—Zoledronate—Paget's disease of bone	0.0033	0.0033	CcSEcCtD
Valsartan—Mediastinal disorder—Zoledronate—Paget's disease of bone	0.0033	0.0033	CcSEcCtD
Valsartan—Vertigo—Risedronate—Paget's disease of bone	0.00329	0.00329	CcSEcCtD
Valsartan—Syncope—Risedronate—Paget's disease of bone	0.00329	0.00329	CcSEcCtD
Valsartan—Dyspepsia—Alendronate—Paget's disease of bone	0.00328	0.00328	CcSEcCtD
Valsartan—Alopecia—Zoledronate—Paget's disease of bone	0.00323	0.00323	CcSEcCtD
Valsartan—Hypersensitivity—Etidronic acid—Paget's disease of bone	0.00322	0.00322	CcSEcCtD
Valsartan—Loss of consciousness—Risedronate—Paget's disease of bone	0.00322	0.00322	CcSEcCtD
Valsartan—Mental disorder—Zoledronate—Paget's disease of bone	0.0032	0.0032	CcSEcCtD
Valsartan—Cough—Risedronate—Paget's disease of bone	0.0032	0.0032	CcSEcCtD
Valsartan—Constipation—Alendronate—Paget's disease of bone	0.00319	0.00319	CcSEcCtD
Valsartan—Angioedema—Pamidronate—Paget's disease of bone	0.00318	0.00318	CcSEcCtD
Valsartan—Malnutrition—Zoledronate—Paget's disease of bone	0.00318	0.00318	CcSEcCtD
Valsartan—Syncope—Pamidronate—Paget's disease of bone	0.00313	0.00313	CcSEcCtD
Valsartan—Arthralgia—Risedronate—Paget's disease of bone	0.00312	0.00312	CcSEcCtD
Valsartan—Chest pain—Risedronate—Paget's disease of bone	0.00312	0.00312	CcSEcCtD
Valsartan—Myalgia—Risedronate—Paget's disease of bone	0.00312	0.00312	CcSEcCtD
Valsartan—Dysgeusia—Zoledronate—Paget's disease of bone	0.00312	0.00312	CcSEcCtD
Valsartan—Anxiety—Risedronate—Paget's disease of bone	0.00311	0.00311	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Risedronate—Paget's disease of bone	0.0031	0.0031	CcSEcCtD
Valsartan—Pruritus—Etidronic acid—Paget's disease of bone	0.0031	0.0031	CcSEcCtD
Valsartan—Back pain—Zoledronate—Paget's disease of bone	0.00308	0.00308	CcSEcCtD
Valsartan—Loss of consciousness—Pamidronate—Paget's disease of bone	0.00306	0.00306	CcSEcCtD
Valsartan—Muscle spasms—Zoledronate—Paget's disease of bone	0.00306	0.00306	CcSEcCtD
Valsartan—Dry mouth—Risedronate—Paget's disease of bone	0.00305	0.00305	CcSEcCtD
Valsartan—Gastrointestinal pain—Alendronate—Paget's disease of bone	0.00305	0.00305	CcSEcCtD
Valsartan—Cough—Pamidronate—Paget's disease of bone	0.00304	0.00304	CcSEcCtD
Valsartan—Vision blurred—Zoledronate—Paget's disease of bone	0.003	0.003	CcSEcCtD
Valsartan—Diarrhoea—Etidronic acid—Paget's disease of bone	0.00299	0.00299	CcSEcCtD
Valsartan—Infection—Risedronate—Paget's disease of bone	0.00297	0.00297	CcSEcCtD
Valsartan—Arthralgia—Pamidronate—Paget's disease of bone	0.00297	0.00297	CcSEcCtD
Valsartan—Myalgia—Pamidronate—Paget's disease of bone	0.00297	0.00297	CcSEcCtD
Valsartan—Urticaria—Alendronate—Paget's disease of bone	0.00296	0.00296	CcSEcCtD
Valsartan—Anxiety—Pamidronate—Paget's disease of bone	0.00296	0.00296	CcSEcCtD
Valsartan—Abdominal pain—Alendronate—Paget's disease of bone	0.00295	0.00295	CcSEcCtD
Valsartan—Shock—Risedronate—Paget's disease of bone	0.00294	0.00294	CcSEcCtD
Valsartan—Nervous system disorder—Risedronate—Paget's disease of bone	0.00293	0.00293	CcSEcCtD
Valsartan—Angioedema—Zoledronate—Paget's disease of bone	0.00291	0.00291	CcSEcCtD
Valsartan—Skin disorder—Risedronate—Paget's disease of bone	0.00291	0.00291	CcSEcCtD
Valsartan—Vertigo—Zoledronate—Paget's disease of bone	0.00286	0.00286	CcSEcCtD
Valsartan—Syncope—Zoledronate—Paget's disease of bone	0.00286	0.00286	CcSEcCtD
Valsartan—Oedema—Pamidronate—Paget's disease of bone	0.00284	0.00284	CcSEcCtD
Valsartan—Anaphylactic shock—Pamidronate—Paget's disease of bone	0.00284	0.00284	CcSEcCtD
Valsartan—Infection—Pamidronate—Paget's disease of bone	0.00283	0.00283	CcSEcCtD
Valsartan—Palpitations—Zoledronate—Paget's disease of bone	0.00281	0.00281	CcSEcCtD
Valsartan—Shock—Pamidronate—Paget's disease of bone	0.0028	0.0028	CcSEcCtD
Valsartan—Loss of consciousness—Zoledronate—Paget's disease of bone	0.0028	0.0028	CcSEcCtD
Valsartan—Nervous system disorder—Pamidronate—Paget's disease of bone	0.00279	0.00279	CcSEcCtD
Valsartan—Thrombocytopenia—Pamidronate—Paget's disease of bone	0.00279	0.00279	CcSEcCtD
Valsartan—Vomiting—Etidronic acid—Paget's disease of bone	0.00278	0.00278	CcSEcCtD
Valsartan—Cough—Zoledronate—Paget's disease of bone	0.00278	0.00278	CcSEcCtD
Valsartan—Rash—Etidronic acid—Paget's disease of bone	0.00276	0.00276	CcSEcCtD
Valsartan—Dermatitis—Etidronic acid—Paget's disease of bone	0.00276	0.00276	CcSEcCtD
Valsartan—Hypersensitivity—Alendronate—Paget's disease of bone	0.00275	0.00275	CcSEcCtD
Valsartan—Headache—Etidronic acid—Paget's disease of bone	0.00274	0.00274	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Risedronate—Paget's disease of bone	0.00273	0.00273	CcSEcCtD
Valsartan—Anorexia—Pamidronate—Paget's disease of bone	0.00271	0.00271	CcSEcCtD
Valsartan—Chest pain—Zoledronate—Paget's disease of bone	0.00271	0.00271	CcSEcCtD
Valsartan—Myalgia—Zoledronate—Paget's disease of bone	0.00271	0.00271	CcSEcCtD
Valsartan—Arthralgia—Zoledronate—Paget's disease of bone	0.00271	0.00271	CcSEcCtD
Valsartan—Insomnia—Risedronate—Paget's disease of bone	0.00271	0.00271	CcSEcCtD
Valsartan—Anxiety—Zoledronate—Paget's disease of bone	0.0027	0.0027	CcSEcCtD
Valsartan—Unspecified disorder of skin and subcutaneous tissue—Zoledronate—Paget's disease of bone	0.00269	0.00269	CcSEcCtD
Valsartan—Paraesthesia—Risedronate—Paget's disease of bone	0.00269	0.00269	CcSEcCtD
Valsartan—Asthenia—Alendronate—Paget's disease of bone	0.00268	0.00268	CcSEcCtD
Valsartan—Dyspnoea—Risedronate—Paget's disease of bone	0.00267	0.00267	CcSEcCtD
Valsartan—Hypotension—Pamidronate—Paget's disease of bone	0.00266	0.00266	CcSEcCtD
Valsartan—Dry mouth—Zoledronate—Paget's disease of bone	0.00265	0.00265	CcSEcCtD
Valsartan—Pruritus—Alendronate—Paget's disease of bone	0.00264	0.00264	CcSEcCtD
Valsartan—Dyspepsia—Risedronate—Paget's disease of bone	0.00263	0.00263	CcSEcCtD
Valsartan—Nausea—Etidronic acid—Paget's disease of bone	0.0026	0.0026	CcSEcCtD
Valsartan—Anaphylactic shock—Zoledronate—Paget's disease of bone	0.0026	0.0026	CcSEcCtD
Valsartan—Oedema—Zoledronate—Paget's disease of bone	0.0026	0.0026	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Pamidronate—Paget's disease of bone	0.00259	0.00259	CcSEcCtD
Valsartan—Gastrointestinal disorder—Risedronate—Paget's disease of bone	0.00258	0.00258	CcSEcCtD
Valsartan—Infection—Zoledronate—Paget's disease of bone	0.00258	0.00258	CcSEcCtD
Valsartan—Fatigue—Risedronate—Paget's disease of bone	0.00258	0.00258	CcSEcCtD
Valsartan—Insomnia—Pamidronate—Paget's disease of bone	0.00257	0.00257	CcSEcCtD
Valsartan—Constipation—Risedronate—Paget's disease of bone	0.00256	0.00256	CcSEcCtD
Valsartan—Shock—Zoledronate—Paget's disease of bone	0.00256	0.00256	CcSEcCtD
Valsartan—Paraesthesia—Pamidronate—Paget's disease of bone	0.00255	0.00255	CcSEcCtD
Valsartan—Diarrhoea—Alendronate—Paget's disease of bone	0.00255	0.00255	CcSEcCtD
Valsartan—Nervous system disorder—Zoledronate—Paget's disease of bone	0.00255	0.00255	CcSEcCtD
Valsartan—Thrombocytopenia—Zoledronate—Paget's disease of bone	0.00254	0.00254	CcSEcCtD
Valsartan—Dyspnoea—Pamidronate—Paget's disease of bone	0.00254	0.00254	CcSEcCtD
Valsartan—Somnolence—Pamidronate—Paget's disease of bone	0.00253	0.00253	CcSEcCtD
Valsartan—Skin disorder—Zoledronate—Paget's disease of bone	0.00252	0.00252	CcSEcCtD
Valsartan—Dyspepsia—Pamidronate—Paget's disease of bone	0.0025	0.0025	CcSEcCtD
Valsartan—Anorexia—Zoledronate—Paget's disease of bone	0.00248	0.00248	CcSEcCtD
Valsartan—Decreased appetite—Pamidronate—Paget's disease of bone	0.00247	0.00247	CcSEcCtD
Valsartan—Dizziness—Alendronate—Paget's disease of bone	0.00247	0.00247	CcSEcCtD
Valsartan—Gastrointestinal disorder—Pamidronate—Paget's disease of bone	0.00246	0.00246	CcSEcCtD
Valsartan—Fatigue—Pamidronate—Paget's disease of bone	0.00245	0.00245	CcSEcCtD
Valsartan—Gastrointestinal pain—Risedronate—Paget's disease of bone	0.00245	0.00245	CcSEcCtD
Valsartan—Constipation—Pamidronate—Paget's disease of bone	0.00243	0.00243	CcSEcCtD
Valsartan—Hypotension—Zoledronate—Paget's disease of bone	0.00243	0.00243	CcSEcCtD
Valsartan—Urticaria—Risedronate—Paget's disease of bone	0.00238	0.00238	CcSEcCtD
Valsartan—Vomiting—Alendronate—Paget's disease of bone	0.00237	0.00237	CcSEcCtD
Valsartan—Musculoskeletal discomfort—Zoledronate—Paget's disease of bone	0.00237	0.00237	CcSEcCtD
Valsartan—Abdominal pain—Risedronate—Paget's disease of bone	0.00237	0.00237	CcSEcCtD
Valsartan—Rash—Alendronate—Paget's disease of bone	0.00235	0.00235	CcSEcCtD
Valsartan—Insomnia—Zoledronate—Paget's disease of bone	0.00235	0.00235	CcSEcCtD
Valsartan—Dermatitis—Alendronate—Paget's disease of bone	0.00235	0.00235	CcSEcCtD
Valsartan—Headache—Alendronate—Paget's disease of bone	0.00234	0.00234	CcSEcCtD
Valsartan—Paraesthesia—Zoledronate—Paget's disease of bone	0.00233	0.00233	CcSEcCtD
Valsartan—Gastrointestinal pain—Pamidronate—Paget's disease of bone	0.00233	0.00233	CcSEcCtD
Valsartan—Dyspnoea—Zoledronate—Paget's disease of bone	0.00232	0.00232	CcSEcCtD
Valsartan—Somnolence—Zoledronate—Paget's disease of bone	0.00231	0.00231	CcSEcCtD
Valsartan—Dyspepsia—Zoledronate—Paget's disease of bone	0.00229	0.00229	CcSEcCtD
Valsartan—Decreased appetite—Zoledronate—Paget's disease of bone	0.00226	0.00226	CcSEcCtD
Valsartan—Abdominal pain—Pamidronate—Paget's disease of bone	0.00225	0.00225	CcSEcCtD
Valsartan—Gastrointestinal disorder—Zoledronate—Paget's disease of bone	0.00224	0.00224	CcSEcCtD
Valsartan—Fatigue—Zoledronate—Paget's disease of bone	0.00224	0.00224	CcSEcCtD
Valsartan—Constipation—Zoledronate—Paget's disease of bone	0.00222	0.00222	CcSEcCtD
Valsartan—Nausea—Alendronate—Paget's disease of bone	0.00222	0.00222	CcSEcCtD
Valsartan—Hypersensitivity—Risedronate—Paget's disease of bone	0.0022	0.0022	CcSEcCtD
Valsartan—Asthenia—Risedronate—Paget's disease of bone	0.00215	0.00215	CcSEcCtD
Valsartan—Gastrointestinal pain—Zoledronate—Paget's disease of bone	0.00212	0.00212	CcSEcCtD
Valsartan—Pruritus—Risedronate—Paget's disease of bone	0.00212	0.00212	CcSEcCtD
Valsartan—Hypersensitivity—Pamidronate—Paget's disease of bone	0.0021	0.0021	CcSEcCtD
Valsartan—Urticaria—Zoledronate—Paget's disease of bone	0.00206	0.00206	CcSEcCtD
Valsartan—Abdominal pain—Zoledronate—Paget's disease of bone	0.00205	0.00205	CcSEcCtD
Valsartan—Diarrhoea—Risedronate—Paget's disease of bone	0.00205	0.00205	CcSEcCtD
Valsartan—Asthenia—Pamidronate—Paget's disease of bone	0.00204	0.00204	CcSEcCtD
Valsartan—Pruritus—Pamidronate—Paget's disease of bone	0.00201	0.00201	CcSEcCtD
Valsartan—Dizziness—Risedronate—Paget's disease of bone	0.00198	0.00198	CcSEcCtD
Valsartan—Diarrhoea—Pamidronate—Paget's disease of bone	0.00195	0.00195	CcSEcCtD
Valsartan—Hypersensitivity—Zoledronate—Paget's disease of bone	0.00191	0.00191	CcSEcCtD
Valsartan—Vomiting—Risedronate—Paget's disease of bone	0.0019	0.0019	CcSEcCtD
Valsartan—Rash—Risedronate—Paget's disease of bone	0.00189	0.00189	CcSEcCtD
Valsartan—Dermatitis—Risedronate—Paget's disease of bone	0.00189	0.00189	CcSEcCtD
Valsartan—Dizziness—Pamidronate—Paget's disease of bone	0.00188	0.00188	CcSEcCtD
Valsartan—Headache—Risedronate—Paget's disease of bone	0.00187	0.00187	CcSEcCtD
Valsartan—Asthenia—Zoledronate—Paget's disease of bone	0.00186	0.00186	CcSEcCtD
Valsartan—Pruritus—Zoledronate—Paget's disease of bone	0.00184	0.00184	CcSEcCtD
Valsartan—Vomiting—Pamidronate—Paget's disease of bone	0.00181	0.00181	CcSEcCtD
Valsartan—Rash—Pamidronate—Paget's disease of bone	0.00179	0.00179	CcSEcCtD
Valsartan—Dermatitis—Pamidronate—Paget's disease of bone	0.00179	0.00179	CcSEcCtD
Valsartan—Headache—Pamidronate—Paget's disease of bone	0.00178	0.00178	CcSEcCtD
Valsartan—Diarrhoea—Zoledronate—Paget's disease of bone	0.00178	0.00178	CcSEcCtD
Valsartan—Nausea—Risedronate—Paget's disease of bone	0.00178	0.00178	CcSEcCtD
Valsartan—Dizziness—Zoledronate—Paget's disease of bone	0.00172	0.00172	CcSEcCtD
Valsartan—Nausea—Pamidronate—Paget's disease of bone	0.00169	0.00169	CcSEcCtD
Valsartan—Vomiting—Zoledronate—Paget's disease of bone	0.00165	0.00165	CcSEcCtD
Valsartan—Rash—Zoledronate—Paget's disease of bone	0.00164	0.00164	CcSEcCtD
Valsartan—Dermatitis—Zoledronate—Paget's disease of bone	0.00164	0.00164	CcSEcCtD
Valsartan—Headache—Zoledronate—Paget's disease of bone	0.00163	0.00163	CcSEcCtD
Valsartan—Nausea—Zoledronate—Paget's disease of bone	0.00154	0.00154	CcSEcCtD
